KLK3 and prostate carcinoma: The clinical significance of the ratio of free prostate-specific antigen (fPSA) to total prostate-specific antigen (tPSA) within the “grey zone” of tPSA levels, ranging from 4 ng/mL to 10 ng/mL, was well established in the diagnosis of prostate cancer.